Aeon (8267) · InitiativeAchieved
Strengthening the Tohoku business base through the acquisition of Marudai Sakurai Pharmacy
First written in FY2017. 1 of 2 entries say "Achieved", first in FY2018-Q2. Latest entry: FY2018-Q2.
2entries
1years
0from disclosures
How it moved
Same theme, other companies
Strengthening the Tohoku drugstore platform through the acquisition of 丸大サクラヰ薬局A theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2018-Q2AchievedAnnual report
「Accordingly, we acquired the shares on 1 September 2017 and made the company a subsidiary.」
All shares of Marudai Sakura Pharmacy were acquired, completing its conversion into a subsidiary on 1 September 2017. The acquisition price was ¥13.72 billion. - FY2017First statedAnnual report
「By acquiring the shares of the company, we will further strengthen the Welcia Group's business base in the Tohoku region and pursue greater efficiency through the sharing of expertise between the two companies.」
Welcia planned to acquire all shares of Marudai Sakura Pharmacy for ¥14.5 billion and make it a subsidiary on 1 September 2017.